Post A Reply
my profile
login
|
register
|
search
|
faq
|
forum home
»
Allstocks.com's Bulletin Board
»
Micro Penny Stocks, Penny Stocks $0.10 & Under
»
CLBE watch for volume increase !! rumors flying
» Post A Reply
Post A Reply
Login Name:
Password:
Message Icon:
Message:
HTML is not enabled.
UBB Code™ is enabled.
[QUOTE]Originally posted by QuestSolver: [QB] Investors can take this to the bank: the promise and efficacy of stem cell therapies will ultimately trump the politics. The medical potential is simply too great to ease suffering, salvage patient lives and save the healthcare industry a massive slug of money. Not to mention throwing off some great investment opportunities. Over 70 companies --the vast majority of them small or microcaps-- are doing some amazing work on stem cell therapies. We have recently unearthed a great smallcap biotech company that deals directly in this realm and plan to bring it to you in the next week or two. In the interim, it would be to your benefit to get to know the ins and outs of the stem cell landscape Here’s a link to several other stem cell companies worldwide. http://www.stem-cell-companies.com/. Be advised, many are in their formative stages. Careful review is warranted. As in every new sector, not all will prosper or even survive. Profits soon. Well, pretty soon. Revenues from current stem cell initiatives should begin to bite in a meaningful way by 2009, exploding to almost $4 billion-plus by 2015. Beyond that, the sky is likely the limit. Investors who see the potential, now, will likely garner the best returns as the scenario unfolds. Nearly $15 billion will be spent over the next decade on both embryonic and adult stem cell research/therapies. States, such as California, recently passed a contentious initiative (Proposition 71), which earmarks $3 billion --by way a pending bond issue-- over the next ten years for stem cell research. Other states are looking at California’s lead to acquire stem cell funding in an effort to make up the R&D shortfall that has resulted from limited federal participation. [b]On the threshold of greatness. And profits[/b] We believe that investors are on the threshold of a whole new and extremely exciting genus of therapies. While acknowledging the controversy around this sector, the over-riding fact is that the formative science is just too compelling to ignore both for healthcare and especially those patients suffering debilitating disease. Is it too early to consider stem cell investing? Would it have been too early to buy Microsoft years ago or to be an early investor with a young(er) Warren Buffett? That’s the type of long-term trend we believe is in the early process of unfolding for stem cell companies. For those investors who have the patience and risk tolerance, there will be some very exciting names coming forward, including those that we will illuminate for readers. The Two Types of Stem Cells. Stem cells differ from other kinds of cells in the body. All stem cells—regardless of their source—have three general properties: they are capable of dividing and renewing themselves for long periods; they are unspecialized; and they can give rise to specialized cell types. Adult stem cells are thought to reside in a specific area of each tissue where they may remain quiescent (non-dividing) for many years until they are activated by disease or tissue injury. The adult tissues reported to contain stem cells include brain, bone marrow, peripheral blood, blood vessels, skeletal muscle, skin and liver. Globally, scientists are trying to find ways to grow adult stem cells in cell cultures and manipulate them to generate specific cell types so they can be used to treat injury or disease. Some examples of potential treatments include replacing the dopamine-producing cells in the brains of Parkinson's patients, developing insulin-producing cells for type I diabetes and repairing damaged heart muscle following a heart attack with cardiac muscle cells. Embryonic stem cells as their name suggests, are derived from embryos after about five days. Specifically, these stem cells are derived from embryos that develop from eggs that have been fertilized in vitro —in an in-vitro fertilization clinic—and then donated for research purposes with the informed consent of the donors. http://www.smallcapnetwork.net/archive/listserv/20060309-1.html [/QB][/QUOTE]
Instant Graemlins
Instant UBB Code™
What is UBB Code™?
Options
Disable Graemlins in this post.
*** Click here to review this topic. ***
Contact Us
|
Allstocks.com Message Board Home
© 1997 - 2021 Allstocks.com. All rights reserved.
Powered by
Infopop Corporation
UBB.classic™ 6.7.2